Jacquie Chirgwin

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

Alan S. Coates, Aparna Keshaviah, Beat Thürlimann et al. · Journal of Clinical Oncology · 2007 · 904 citations

Medicine, Oncology, Breast Oncology +13

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

Jacquie Chirgwin, Anita Giobbie‐Hurder, Alan S. Coates et al. · Journal of Clinical Oncology · 2016 · 253 citations · Full text

Medicine, Oncology, Breast Oncology +12

Analyses Adjusting for Selective Crossover Show Improved Overall Survival With Adjuvant Letrozole Compared With Tamoxifen in the BIG 1-98 Study

Marco Colleoni, Anita Giobbie‐Hurder, Meredith M. Regan et al. · Journal of Clinical Oncology · 2011 · 144 citations · Full text

Medicine, Oncology, Pharmacology +16

Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial

Diana Crivellari, Zhuoxin Sun, Alan S. Coates et al. · Journal of Clinical Oncology · 2008 · 141 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

Medicine, Gynecology, Oncology +13